Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC BMS-986121 | 313671-26-0 | 100.0% | C15H9Cl2N3O2S | 25 MG
SDP

Catalog No. 5000352534
Encompass_Preferred

BMS-986121 is a positive allosteric modulator (PAM) of the μ opioid receptor, developed from patent WO2014107344. It is built on a novel chemical scaffold, representing a new chemotype for μ receptor PAMs.

  • Potent positive allosteric modulator of the μ opioid receptor.
  • Augments β-arrestin-recruitment response.
  • Increases inhibition of adenylyl cyclase activity.
  • Enhances the potency of endomorphin-I and leu-enkephalin in cAMP-accumulation assays.

Catalog No. 50-003-52534 Supplier Medchemexpress LLC Supplier No. 25MGHY141515
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BMS-986121 is a positive allosteric modulator (PAM) of the μ opioid receptor, developed from patent WO2014107344. It is built on a novel chemical scaffold, representing a new chemotype for μ receptor PAMs.

  • Potent positive allosteric modulator of the μ opioid receptor.
  • Augments β-arrestin-recruitment response.
  • Increases inhibition of adenylyl cyclase activity.
  • Enhances the potency of endomorphin-I and leu-enkephalin in cAMP-accumulation assays.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.